rs16867464

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_201548.5(CERKL):​c.238+25031G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 152,170 control chromosomes in the GnomAD database, including 1,325 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1325 hom., cov: 32)

Consequence

CERKL
NM_201548.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0180

Publications

1 publications found
Variant links:
Genes affected
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]
CERKL Gene-Disease associations (from GenCC):
  • CERKL-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 26
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CERKL
NM_201548.5
MANE Select
c.238+25031G>A
intron
N/ANP_963842.1Q49MI3-2
CERKL
NM_001030311.3
c.238+25031G>A
intron
N/ANP_001025482.1Q49MI3-1
CERKL
NM_001160277.2
c.238+25031G>A
intron
N/ANP_001153749.1Q49MI3-9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CERKL
ENST00000410087.8
TSL:1 MANE Select
c.238+25031G>A
intron
N/AENSP00000386725.3Q49MI3-2
CERKL
ENST00000339098.9
TSL:1
c.238+25031G>A
intron
N/AENSP00000341159.5Q49MI3-1
CERKL
ENST00000374970.6
TSL:1
c.238+25031G>A
intron
N/AENSP00000364109.2Q49MI3-3

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17169
AN:
152052
Hom.:
1322
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0306
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.167
Gnomad ASJ
AF:
0.0770
Gnomad EAS
AF:
0.217
Gnomad SAS
AF:
0.0610
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.0945
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.113
AC:
17179
AN:
152170
Hom.:
1325
Cov.:
32
AF XY:
0.119
AC XY:
8823
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0307
AC:
1276
AN:
41566
American (AMR)
AF:
0.167
AC:
2549
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0770
AC:
267
AN:
3468
East Asian (EAS)
AF:
0.217
AC:
1120
AN:
5162
South Asian (SAS)
AF:
0.0613
AC:
296
AN:
4832
European-Finnish (FIN)
AF:
0.216
AC:
2286
AN:
10562
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.134
AC:
9145
AN:
67994
Other (OTH)
AF:
0.0969
AC:
204
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
770
1540
2311
3081
3851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
712
Bravo
AF:
0.106
Asia WGS
AF:
0.164
AC:
569
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.5
DANN
Benign
0.46
PhyloP100
-0.018
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16867464; hg19: chr2-182496465; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.